Our team
Transforming immunotherapy with Alphamerยฎ technology
Who we are
Our industry-leading executive team is supported by our valued Board, and a network of experienced advisors who form our SAB. Our passionate scientists bring expertise from the fields of immunology, oncology, microbiology and virology, within both innovative biotechs and big pharma. Together, we are working to bring novel immunotherapies to areas of high unmet need.
Leadership team
Meet our expert team
-
Jennifer Schneider
,
Chief Executive Officer & Director, Director -
Samantha Macro
,
Chief Financial Officer -
Debra Barker
,
Chief Medical Officer -
Helen Bright
,
Chief Scientific Officer
Board of directors
Meet our Board
-
Jennifer Schneider
Chief Executive Officer & Director, Director -
Professor David Roblin
Chair of the Board of Directors -
Antonio Felici
Director -
Stuart Lawson
Director -
Sebastian Kreuz
Director -
Camilla Petrycer-Hansen
Director -
Henni-Karoliina Ropponen
Director
Advisors
Meet our scientific advisors
-
Ron Gladue
,
Chair of the SAB -
Aleksandar Danilovski
,
SAB Member -
Todd A. Black
,
SAB Member -
David Melnick
,
SAB Member -
Mike Westby
,
SAB Member
